Total Payments
$23,352
2024 Payments
$7,786
Companies
5
Transactions
25
Medicare Patients
777
Medicare Billing
$93,996
Payment Breakdown by Category
Consulting$21,290 (91.2%)
Travel$1,240 (5.3%)
Food & Beverage$822.06 (3.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $21,290 | 10 | 91.2% |
| Travel and Lodging | $1,240 | 3 | 5.3% |
| Food and Beverage | $822.06 | 12 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $22,907 | 20 | $0 (2024) |
| Cleerly, Inc. | $325.34 | 2 | $0 (2024) |
| La Jolla Pharmaceutical Company | $88.47 | 1 | $0 (2019) |
| Vapotherm Inc | $20.16 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $10.58 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,786 | 11 | Gilead Sciences, Inc. ($7,461) |
| 2023 | $2,021 | 4 | Gilead Sciences, Inc. ($2,021) |
| 2022 | $8,655 | 5 | Gilead Sciences, Inc. ($8,655) |
| 2021 | $4,770 | 2 | Gilead Sciences, Inc. ($4,770) |
| 2019 | $108.63 | 2 | La Jolla Pharmaceutical Company ($88.47) |
| 2018 | $10.58 | 1 | Janssen Pharmaceuticals, Inc ($10.58) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/26/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $6,020.00 | General |
| Category: COVID-19 | ||||||
| 03/22/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $44.99 | General |
| Category: COVID-19 | ||||||
| 03/22/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $44.99 | General |
| Category: COVID-19 | ||||||
| 03/22/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $33.65 | General |
| Category: COVID-19 | ||||||
| 03/22/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $33.65 | General |
| Category: COVID-19 | ||||||
| 03/21/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $303.97 | General |
| Category: COVID-19 | ||||||
| 03/21/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $74.99 | General |
| Category: COVID-19 | ||||||
| 03/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.14 | General |
| 03/04/2024 | Cleerly, Inc. | Cleerly Ischemia (Device), Cleerly Labs | Food and Beverage | In-kind items and services | $149.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/16/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $878.44 | General |
| Category: COVID-19 | ||||||
| 01/08/2024 | Cleerly, Inc. | Cleerly Ischemia (Device), Cleerly Labs | Food and Beverage | In-kind items and services | $176.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $1,230.00 | General |
| Category: COVID-19 | ||||||
| 10/12/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $119.10 | General |
| Category: COVID-19 | ||||||
| 10/12/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $57.36 | General |
| Category: COVID-19 | ||||||
| 09/20/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $615.00 | General |
| Category: COVID-19 | ||||||
| 12/20/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $1,850.00 | General |
| Category: COVID-19 | ||||||
| 12/20/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $1,025.00 | General |
| Category: COVID-19 | ||||||
| 06/29/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $1,850.00 | General |
| Category: COVID-19 | ||||||
| 03/24/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $1,260.00 | General |
| Category: COVID-19 | ||||||
| 02/24/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $2,670.00 | General |
| Category: COVID-19 | ||||||
| 11/23/2021 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| 08/24/2021 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $1,470.00 | General |
| Category: COVID-19 | ||||||
| 11/20/2019 | Vapotherm Inc | Precision Flow (Device) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Respiratory | ||||||
| 10/27/2019 | La Jolla Pharmaceutical Company | — | Food and Beverage | In-kind items and services | $88.47 | General |
| 12/14/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 61 | 61 | $89,456 | $8,226 |
| 2022 | 4 | 129 | 130 | $176,380 | $16,650 |
| 2021 | 4 | 107 | 107 | $141,974 | $13,905 |
| 2020 | 6 | 480 | 482 | $478,871 | $55,215 |
Total Patients
777
Total Services
780
Medicare Billing
$93,996
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 19 | 19 | $36,307 | $3,398 | 9.4% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 23 | 23 | $34,076 | $3,234 | 9.5% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 19 | 19 | $19,073 | $1,593 | 8.4% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 51 | 52 | $77,041 | $6,935 | 9.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 30 | 30 | $57,327 | $5,645 | 9.8% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 35 | 35 | $35,134 | $3,330 | 9.5% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 13 | 13 | $6,879 | $740.68 | 10.8% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 47 | 47 | $67,750 | $6,636 | 9.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 24 | 24 | $45,862 | $4,280 | 9.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 23 | 23 | $21,806 | $2,289 | 10.5% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 13 | 13 | $6,556 | $700.59 | 10.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 148 | 150 | $187,458 | $20,980 | 11.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 86 | 86 | $145,792 | $16,034 | 11.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 157 | 157 | $122,124 | $14,784 | 12.1% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 50 | 50 | $19,969 | $2,669 | 13.4% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2020 | 18 | 18 | $2,646 | $613.29 | 23.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 21 | 21 | $882.00 | $134.52 | 15.3% |
About Dr. Michael Roshon, MD
Dr. Michael Roshon, MD is a Emergency Medicine healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518916774.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Roshon, MD has received a total of $23,352 in payments from pharmaceutical and medical device companies, with $7,786 received in 2024. These payments were reported across 25 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($21,290).
As a Medicare-enrolled provider, Roshon has provided services to 777 Medicare beneficiaries, totaling 780 services with total Medicare billing of $93,996. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Emergency Medicine
- Location Boston, MA
- Active Since 05/08/2006
- Last Updated 02/04/2026
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1518916774
Products in Payments
- Veklury (Drug) $19,581
- Cleerly Ischemia (Device) $325.34
- Precision Flow (Device) $20.16
- XARELTO (Drug) $10.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Boston
Sunil Kapur, Md, MD
Emergency Medicine — Payments: $542,263
Emergency Medicine $542,263
Joshua Goldstein, Md, Phd, MD, PHD
Emergency Medicine — Payments: $340,169
Emergency Medicine $340,169
Elissa Perkins, Md, MD
Emergency Medicine — Payments: $250,334
Emergency Medicine $250,334
Adaira Landry, M.d, M.D
Emergency Medicine — Payments: $211,020
Emergency Medicine $211,020
Dr. Christopher Baugh, M.d., Mba, M.D., MBA
Emergency Medicine — Payments: $172,710
Emergency Medicine $172,710
Dr. John Nagurney, Md, MD
Emergency Medicine — Payments: $137,834
Emergency Medicine $137,834